OrbiMed’s BioLineRX BLRX Stock Holding History

OrbiMed’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,731	Closed	-$114K	–	152
2020 Q3	$114K	Hold	1,731	–	–	﹤0.01%	143
2020 Q2	$118K	Hold	1,731	–	–	﹤0.01%	135
2020 Q1	$92K	Hold	1,731	–	–	﹤0.01%	142
2019 Q4	$156K	Hold	1,731	–	–	﹤0.01%	135
2019 Q3	$183K	Hold	1,731	–	–	﹤0.01%	115
2019 Q2	$379K	Hold	1,731	–	–	0.01%	127
2019 Q1	$447K	Hold	1,731	–	–	0.01%	122
2018 Q4	$454K	Hold	1,731	–	–	0.01%	127
2018 Q3	$1.11M	Hold	1,731	–	–	0.01%	145
2018 Q2	$924K	Hold	1,731	–	–	0.01%	141
2018 Q1	$904K	Hold	1,731	–	–	0.01%	133
2017 Q4	$1.13M	Hold	1,731	–	–	0.01%	126
2017 Q3	$1.16M	Hold	1,731	–	–	0.01%	133
2017 Q2	$878K	Hold	1,731	–	–	0.01%	131
2017 Q1	$998K	Hold	1,731	–	–	0.01%	130
2016 Q4	$956K	Hold	1,731	–	–	0.01%	124
2016 Q3	$1.19M	Hold	1,731	–	–	0.01%	129
2016 Q2	$831K	Hold	1,731	–	–	0.01%	129
2016 Q1	$1.06M	Hold	1,731	–	–	0.01%	137
2015 Q4	$1.35M	Hold	1,731	–	–	0.01%	120
2015 Q3	$1.59M	Sell	1,731 -161	-9%	-$172K	0.02%	124
2015 Q2	$3.02M	Hold	1,892	–	–	0.03%	123
2015 Q1	$2.4M	Hold	1,892	–	–	0.02%	124
2014 Q4	$1.84M	Hold	1,892	–	–	0.02%	123
2014 Q3	$1.75M	Hold	1,892	–	–	0.02%	124
2014 Q2	$2.36M	Hold	1,892	–	–	0.03%	125
2014 Q1	$2.53M	Hold	1,892	–	–	0.03%	130
2013 Q4	$3.19M	Sell	1,892 -333	-15%	-$537K	0.05%	107
2013 Q3	$2.92M	Sell	2,225 -424	-16%	-$501K	0.05%	113
2013 Q2	$2.58M	Buy	+2,649	New	+$2.74M	0.05%	117

Other funds holding BLRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

OrbiMed's BLRX Position: Q4 2020 in Review

OrbiMed sold out of BioLineRX (BLRX) in Q4 2020, closing a stake of 1,731 shares — an estimated $114K sold.

OrbiMed first reported a position in BLRX in Q2 2013 and held it in 30 quarters. The position peaked at $3.19M in Q4 2013. 21 funds tracked by Wall St. Rank hold BLRX as of Q4 2020.

OrbiMed reported no remaining BioLineRX position as of Q4 2020 after selling out during the quarter.
OrbiMed sold 1,731 BioLineRX shares in Q4 2020, an estimated $114K.
OrbiMed first reported a position in BioLineRX in Q2 2013 and held it in 30 quarters.
OrbiMed's BioLineRX position peaked at $3.19M in Q4 2013.
21 funds tracked by Wall St. Rank held BioLineRX as of Q4 2020.

Based on OrbiMed's 13F filing for Q4 2020, filed 16 Feb 2021.